Mersana Therapeutics Inc (NAS:MRSN)
$ 2.01 0.17 (9.24%) Market Cap: 246.57 Mil Enterprise Value: 98.35 Mil PE Ratio: 0 PB Ratio: 28.71 GF Score: 39/100

Mersana Therapeutics Inc UPLIFT Data Update Call Transcript

Jul 27, 2023 / 12:00PM GMT
Release Date Price: $1.07 (-72.63%)
Operator

Good day, and welcome to the Mersana Therapeutics Conference Call. (Operator Instructions) Please note that today's event is being recorded.

At this time, I would like to turn the call over to Mersana's Senior Vice President of Investor Relations and Corporate Communications, Jason Fredette. Please go ahead.

Jason Fredette
Mersana Therapeutics, Inc. - SVP of IR & Corporate Communications

Thank you, operator, and good morning, everyone.

Before we begin, please note that this call will contain forward-looking statements within the meaning of federal securities laws. These statements may include, but are not limited to, those related to the therapeutic potential of our product candidates and our platforms, business strategy, clinical trial execution, regulatory engagements, plans and objectives, business development efforts, cost, operating expenses, cost reduction efforts and cash runway.

Each of these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot